5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study

Ascierto, Paolo A.; Dreno, Brigitte; Larkin, James; Ribas, Antoni; Liszkay, Gabriella; Maio, Michele; Mandala, Mario; Demidov, Lev; Stroyakovskiy, Daniil; Thomas, Luc; de la Cruz-Merino, Luis; Atkinson, Victoria; Dutriaux, Caroline; Garbe, Claus; Hsu, Jessie; Jones, Surai; Li, Haocheng; McKenna, Edward; Voulgari, Athina; McArthur, Grant A.

dc.contributor.author	Garbe, Claus
dc.date.accessioned	2022-05-25T07:29:43Z
dc.date.available	2022-05-25T07:29:43Z
dc.date.issued	2021
dc.identifier.issn	1557-3265
dc.identifier.uri	http://hdl.handle.net/10900/127400
dc.language.iso	en	de_DE
dc.publisher	Amer Assoc Cancer Research	de_DE
dc.relation.uri	http://dx.doi.org/10.1158/1078-0432.CCR-21-0809	de_DE
dc.subject.ddc	610	de_DE
dc.title	5-Year Outcomes with Cobimetinib plus Vemurafenib in BRAFV600 Mutation–Positive Advanced Melanoma: Extended Follow-up of the coBRIM Study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20211125174918_00425
utue.publikation.seiten	5225-5235	de_DE
utue.personen.roh	Ascierto, Paolo A.
utue.personen.roh	Dreno, Brigitte
utue.personen.roh	Larkin, James
utue.personen.roh	Ribas, Antoni
utue.personen.roh	Liszkay, Gabriella
utue.personen.roh	Maio, Michele
utue.personen.roh	Mandala, Mario
utue.personen.roh	Demidov, Lev
utue.personen.roh	Stroyakovskiy, Daniil
utue.personen.roh	Thomas, Luc
utue.personen.roh	de la Cruz-Merino, Luis
utue.personen.roh	Atkinson, Victoria
utue.personen.roh	Dutriaux, Caroline
utue.personen.roh	Garbe, Claus
utue.personen.roh	Hsu, Jessie
utue.personen.roh	Jones, Surai
utue.personen.roh	Li, Haocheng
utue.personen.roh	McKenna, Edward
utue.personen.roh	Voulgari, Athina
utue.personen.roh	McArthur, Grant A.
dcterms.isPartOf.ZSTitelID	Clinical Cancer Research	de_DE
dcterms.isPartOf.ZS-Issue	19	de_DE
dcterms.isPartOf.ZS-Volume	27	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE